Grigoris Zoidis

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Viruses

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

ChemMedChem

National and Kapodistrian University of Athens Faculty of Pharmacy

National and Kapodistrian University of Athens Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens Faculty of Pharmacy Jan 02 2012

Greece

Associate Professor :: Pharmaceutical Chemistry

Education History

National and Kapodistrian University of Athens Faculty of Pharmacy

Greece

PHD :: Pharmaceutical Chemistry

Publications

George Fytas, Grigoris Zoidis, Antonios Drakopoulos, Martin Craig Taylor, John M Kelly, Alexandra Tsatsaroni, Andrew Tsotinis
New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies. ACS medicinal chemistry letters 15 (7) (2024)
George Fytas, Grigoris Zoidis, Antonios Drakopoulos, Martin Craig Taylor, John M Kelly, Alexandra Tsatsaroni, Andrew Tsotinis
New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies. ACS medicinal chemistry letters 15 (7) (2024)
Erofili Giannakopoulou, Ifigeneia Akrani, George Mpekoulis, Efseveia Frakolaki, Marios Dimitriou, Vassilios Myrianthopoulos, Niki Vassilaki, Grigoris Zoidis
Novel Pyrazino[1,2- a ]indole-1,3(2 H ,4 H )-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights. Viruses 16 (8) (2024)
Erofili Giannakopoulou, Ifigeneia Akrani, George Mpekoulis, Efseveia Frakolaki, Marios Dimitriou, Vassilios Myrianthopoulos, Niki Vassilaki, Grigoris Zoidis
Novel Pyrazino[1,2- a ]indole-1,3(2 H ,4 H )-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights. Viruses 16 (8) (2024)
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E Woodson, Razia Tajwar, John E Tavis, Grigoris Zoidis
N -Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules (Basel, Switzerland) 29 (12) (2024)
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E Woodson, Razia Tajwar, John E Tavis, Grigoris Zoidis
N -Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules (Basel, Switzerland) 29 (12) (2024)
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E Woodson, Razia Tajwar, John E Tavis, Grigoris Zoidis
N -Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules (Basel, Switzerland) 29 (12) (2024)
Dimitrios Moianos, Georgia-Myrto Prifti, Maria Makri, Grigoris Zoidis
Targeting Metalloenzymes: The "Achilles' Heel" of Viruses and Parasites. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Dimitrios Moianos, Georgia-Myrto Prifti, Maria Makri, Grigoris Zoidis
Targeting Metalloenzymes: The "Achilles' Heel" of Viruses and Parasites. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Vasiliki Pardali, Erofili Giannakopoulou, George Mpekoulis, Vassilina Tsopela, Georgios Panos, Martin Craig Taylor, John M Kelly, Niki Vassilaki, Grigoris Zoidis
Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal Activity. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Jehad Hamdy, Nouran Emadeldin, Mostafa M Hamed, Efseveia Frakolaki, Sotirios Katsamakas, Niki Vassilaki, Grigoris Zoidis, Anna Katharina Herta Hirsch, Mohammad Abdel-Halim, Ashraf H Abadi
Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Argyro Vontzalidou, Sapfo-Maria Dimitrakoudi, Konstantinos Tsoukalas, Grigoris Zoidis, Eliza Chaita, Evanthia Dina, Christina Cheimonidi, Ioannis P Trougakos, George Lamprinidis, Alexios-Leandros Skaltsounis, Emmanuel Mikros, Nektarios Aligiannis
Development of Stilbenoid and Chalconoid Analogues as Potent Tyrosinase Modulators and Antioxidant Agents. Antioxidants (Basel, Switzerland) 11 (8) (2022)
Antonios Drakopoulos, Dimitrios Moianos, Georgia-Myrto Prifti, Grigoris Zoidis, Michael Decker
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype. ChemMedChem 17 (14) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Mai H A Mousa, Nermin S Ahmed, Kai Schwedtmann, Efseveia Frakolaki, Niki Vassilaki, Grigoris Zoidis, Jan J Weigand, Ashraf H Abadi
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Georgia-Myrto Prifti, Dimitrios Moianos, Erofili Giannakopoulou, Vasiliki Pardali, John E Tavis, Grigoris Zoidis
Recent Advances in Hepatitis B Treatment. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Grigoris Zoidis, Eftichia Kritsi, Paulina Lecinska, Marija Ivanov, Panagiotis Zoumpoulakis, Marina D Soković, Marco Catto
The Triazole Ring as a Privileged Scaffold for Putative Antifungals: Synthesis and Evaluation of a Series of New Analogues. ChemMedChem 16 (1) (2020)
Erofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, Vasileios Siozos, Vassilios Myrianthopoulos, Emmanuel Mikros, Martin C Taylor, John M Kelly, Niki Vassilaki, Grigoris Zoidis
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species. MedChemComm 10 (6) (2019)
Grigoris Zoidis, Andrew Tsotinis, Alexandra Tsatsaroni, Martin C Taylor, John M Kelly, Antonia Efstathiou, Despina Smirlis, George Fytas
Lipophilic conformationally constrained spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acid analogues as trypanocidal and leishmanicidal agents: An extended SAR study. Chemical biology & drug design 91 (2) (2017)

Grigoris Zoidis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Grigoris Zoidis